1518 / 1544
Schwartz
IJROBP 2005
“Dose heterogeneity is an option to further
escalate the dose in the target rather than a
price to pay for using IMRT”
Dose escalation 3D vs IMRT: 6% vs 17-35%
Grills
IJROBP 2003
Dose escalation: IMRT>>25-30%
St Hilare
Radiot Oncol 2009
Dose escalation: >78 Gy in 5/7 cases
3D vs IMRT: PTV Dose escalation in the target”